SEARCH

SEARCH BY CITATION

References

  • Azhakanandam, K., Weissinger, S.M., Nicholson, J.S., Qu, R. and Weissinger, A.K. (2007) Amplicon-plus targeting technology (APTT) for rapid production of a highly unstable vaccine protein in tobacco plants. Plant Mol. Biol. 63, 393404.
  • Azzoni, A.R., Kusnadi, A.R., Miranda, E.A. and Nikolov, Z.L. (2002) Recombinant aprotinin produced in transgenic corn seed: extraction and purification studies. Biotechnol. Bioeng. 80, 268276.
  • Beierlein, W., Scheule, A.M., Dietrich, W. and Ziemer, G. (2005) Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann. Thorac. Surg. 79, 741748.
  • Belson, N.A. (2000) US regulation of agricultural biotechnology: an overview. AgBioForum, 3, 268280.
  • Benchabane, M., Goulet, C., Rivard, D., Faye, L., Gomord, V. and Michaud, D. (2008) Preventing unintended proteolysis in plant protein biofactories. Plant Biotechnol. J. 6, 633648.
  • Benchabane, M., Saint-Jore-Dupas, C., Faye, L., Gomord, V. and Michaud, D. (2009) Nucleocytoplasmic transit of human alpha1-antichymotrypsin in tobacco leaf epidermal cells. Plant Biotechnol. J. 7, 161171.
  • Concetti, A., Angeletti, M., Fioretti, E. and Ascoli, F. (1989) Selective oxidation of methionine residues in Kunitz-type protease inhibitors. Biol. Chem. Hoppe Seyler, 370, 723728.
  • Datamonitor (2008) Monoclonal Antibodies Report: 2008 Update. London: Business Information Center.
  • Dawson, W.O. and Lehto, K.M. (1990) Regulation of tobamovirus gene expression. Adv. Virus Res. 38, 307342.
  • Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R., Goedert, J.J., Buchbinder, S.P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C. and Detels, R. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273, 18561862.
  • Doran, P.M. (2000) Foreign protein production in plant tissue cultures. Curr. Opin. Biotechnol. 11, 199204.
  • Du, H., Cameron, T.L., Garger, S.J., Pogue, G.P., Hamm, L.A., White, E., Hanley, K.M. and Grabowski, G.A. (2008) Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice. J. Lipid Res. 49, 16461657.
  • European Food Safety Authority (2009) Scientific opinion on guidance for the risk assessment of genetically modified plants used for non-food or non-feed purposes. EFSA J. 1164, 142.
  • Fischer, R., Twyman, R.M. and Schillberg, S. (2003) Production of antibodies in plants and their use for global health. Vaccine, 21, 820825.
  • Fitzmaurice, W.P., inventor (2002) Interspecific Nicotiana Hybrids and their Progeny. US Patent no. 6,344,597.
  • Floss, D.M., Falkenburg, D. and Conrad, U. (2007) Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res. 16, 315332.
  • Fritz, H. and Wunderer, G. (1983) Biochemistry and applications of aprotinin, the Kallikrein inhibitor from bovine organs. Arzneimittelforschung, 33, 479494.
  • Gaertner, H., Cerini, F., Escola, J.M., Kuenzi, G., Melotti, A., Offord, R., Rossitto-Borlat, I., Nedellec, R., Salkowitz, J., Gorochov, G., Mosier, D. and Hartley, O. (2008) Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide. Proc. Natl Acad. Sci. USA, 105, 1770617711.
  • Garber, K. (2001) Biotech industry faces new bottleneck. Nat. Biotechnol. 19, 184185.
  • Gardner, G.P., Cohen, M., Rosenfield, S.I., Nagashima, K.A., Maddon, P.J. and Olson, W.C. (2003) Immunotoxicology of PRO 140, a Humanized Anti-CCR5 Monoclonal Antibody for HIV-1 Therapy. Abstract 647, 41st Annual Meeting of the Infectious Diseases Society of America, October 9-12, San Diego, California.
  • Gelderman, M.P., Oliver, K.L., Yazdani, A.T., Murray, G.J., Miller, G.J., Cameron, T.I., Garger, S.J., Turpen, T.H., Holtz, R.B. and Brady, R.O. (2004) Preclinical studies with plant-produced alphagalactosidase A in Fabry mice show potential for replacement therapy. Preclinica, 2, 6774.
  • Giritch, A., Marillonnet, S., Engler, C., Van Eldik, G., Botterman, J., Klimyuk, V. and Gleba, Y. (2006) Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc. Natl Acad. Sci. USA, 103, 1470114706.
  • Gleba, Y., Klimyuk, V. and Marillonnet, S. (2005) Magnifection – a new platform for expressing recombinant vaccines in plants. Vaccine, 23, 20422048.
  • Gleba, Y., Klimyuk, V. and Marillonnet, S. (2007) Viral vectors for the expression of proteins in plants. Curr. Opin. Biotechnol. 18, 134141.
  • Gleba, Y., Marillonnet, S. and Klimyuk, V. (2008) Plant virus vectors (gene expression systems). Enc. Virology, 3rd edn, 4, 229237.
  • Goodman, M. (2009) Market watch: sales of biologics to show robust growth through to 2013. Nat. Rev. Drug Discov. 8, 837.
  • Greb, E. (2009) Charting a pathway to follow-on biologics. Pharm. Tech. 33, 3642.
  • Grill, L.K., Palmer, K.E. and Pogue, G.P. (2005) Use of plant viruses for production of plant-derived human vaccines. Crc. Crit. Rev. Plant Sci. 24, 309323.
  • Hellens, R.P., Allan, A.C., Friel, E.N., Bolitho, K., Grafton, K., Templeton, M.D., Karunairetnam, S., Gleave, A.P. and Laing, W.A. (2005) Transient expression vectors for functional genomics, quantification of promoter activity and RNA silencing in plants. Plant Methods, 1, 13.
  • Hiatt, A. and Pauly, M. (2006) Monoclonal antibodies from plants: a new speed record. Proc. Natl Acad. Sci. USA, 103, 1464514646.
  • Hoentjen, F. and Van Bodegraven, A.A. (2009) Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. World J. Gastroenterol. 15, 20672073.
  • Jacobson, J.M., Saag, M.S., Thompson, M.A., Fischl, M.A., Liporace, R., Reichman, R.C., Redfield, R.R., Fichtenbaum, C.J., Zingman, B.S., Patel, M.C., Murga, J.D., Pemrick, S.M., D’Ambrosio, P., Michael, M., Kroger, H., Ly, H., Rotshteyn, Y., Buice, R., Morris, S.A., Stavola, J.J., Maddon, P.J., Kremer, A.B. and Olson, W.C. (2008) Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults. J. Infect. Dis. 198, 13451352.
  • Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. and Thunet, M.J. (2008) Cancer statistics, 2008. CA Cancer J. Clin. 58, 7196.
  • Joh, L.D. and VanderGheynst, J.S. (2006) Agro-infiltration of plant tissues for production of high-value recombinant proteins: an alternative to production in transgenic crops. J. Sci. Food Agric. 86, 20022004.
  • La Merie Business Intelligence. (2009) Top 20 Biologics 2008. Avialable at: http://www.lamerie.com (accessed on 9 March 2009).
  • Laskowski Jr, M. and Kato, I. (1980) Protein inhibitors of proteinases. Annu. Rev. Biochem. 49, 593626.
  • Lico, C., Chen, Q. and Santi, L. (2008) Viral vectors for production of recombinant proteins in plants. J. Cell. Physiol. 216, 366377.
  • Ma, J.K.C., Drake, P.M.W. and Christou, P. (2003) The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Genet. 4, 794805.
  • Maffulli, N., Walley, G., Sayana, M.K., Longo, U.G. and Denaro, V. (2008) Eccentric calf muscle training in athletic patients with Achilles tendinopathy. Disabil. Rehabil. 30, 16771684.
  • Mallory, A.C., Parks, G., Endres, M.W., Baulcombe, D., Bowman, L.H., Pruss, G.J. and Vance, V.B. (2002) The amplicon-plus system for high-level expression of transgenes in plants. Nat. Biotechnol. 20, 622625.
  • Mangano, D.T., Tudor, I.C. and Dietzel, C. (2006) The risk associated with aprotinin in cardiac surgery. N. Engl. J. Med. 354, 353365.
  • Mangano, D.T., Miao, Y., Vuylsteke, A., Tudor, I.C., Juneja, R., Filipescu, D., Hoeft, A., Fontes, M.L., Hillel, Z., Ott, E., Titov, T., Dietzel, C. and Levin, J. (2007) Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA, 297, 471479.
  • Marillonnet, S., Giritch, A., Gils, M., Kandzia, R., Klimyuk, V. and Gleba, Y. (2004) In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc. Natl Acad. Sci. USA, 101, 68526857.
  • McCormick, A.A., Kumagai, M.H., Hanley, K., Turpen, T.H., Hakim, I., Grill, L.K., Tusé, D., Levy, S. and Levy, R. (1999) Rapid production of specific vaccines for lymphoma by expression of tumor-derived single-chain Fv epitopes in tobacco plants. Proc. Natl Acad. Sci. USA, 96, 703708.
  • McCormick, A.A.S., Reinl, S.J., Cameron, T.I., Vojdani, F., Fronefield, M., Levy, R. and Tusé, D. (2003) Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. J. Immunol. Methods, 278, 95104.
  • McCormick, A.A., Reddy, S., Reinl, S.J., Cameron, T.I., Czerwinkski, D.K., Vojdani, F., Hanley, K.M., Garger, S.J., White, E.L., Novak, J., Barrett, J., Holtz, R.B., Tusé, D. and Levy, R. (2008) Plant-produced idiotype vaccines for the treatment of non-Hodgkin’s lymphoma: safety and immunogenicity in a phase I clinical study. Proc. Natl Acad. Sci. USA, 105, 1013110136.
  • Moore, J.P., Trkola, A. and Dragic, T. (1997) Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9, 551562.
  • Munoz, J.J., Birkmeyer, N.J.O., Birkmeyer, J.D., O’Conner, G.T. and Dacy, K.J. (1999) Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery? A meta-analysis. Circulation, 99, 8189.
  • Murga, J.D., Franti, M., Pevear, D.C., Maddon, P.J. and Olson, W.C. (2006) Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 50, 32893296.
  • O’Keefe, B.R., Vojdani, F., Buffa, V., Shattock, R., Montefiori, D.C., Bakke, J., Mirsalis, J., D’Andrea, A.-L., Hume, S., Bratcher, B., Saucedo, C.J., McMahon, J.B., Pogue, G.P. and Palmer, K.E. (2009) Scalable manufacturing of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy profiles as a topical microbicide component. Proc. Natl Acad. Sci. USA, 106, 60996104.
  • Olson, W.C. and Jacobson, J.M. (2009) HIV CCR5 monoclonal antibodies for HIV-1 therapy. Curr. Opin. HIV AIDS, 4, 104111.
  • Olson, W.C., Rabut, G.E., Nagashima, K.A., Tran, D.N., Anselma, D.J., Monard, S.P., Segal, J.P., Thompson, D.A., Kajumo, F., Guo, Y., Moore, J.P., Maddon, P.J. and Dragic, T. (1999) Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. J. Virol. 73, 41454155.
  • Orchard, J., Massey, A., Brown, R., Cardon-Dunbar, A. and Hofmann, J. (2008) Successful management of tendinopathy with injections of the MMP-inhibitor aprotinin. Clin. Orthop. Relat. Res. 466, 16251632.
  • Palmer, K.E., Benko, A., Doucette, S.A., Cameron, T.I., Foster, T., Hanley, K.M., McCormick, A.A., McCulloch, M., Pogue, G.P., Smith, M.L. and Christensen, N.D. (2006) Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes. Vaccine, 24, 55165525.
  • Plasson, C., Michel, R., Lienard, D., Saint-Jore-Dupas, C., Sourrouille, C., De March, G.G. and Gomord, V. (2009) Production of recombinant proteins in suspension-cultured plant cells. Methods Mol. Biol. 483, 145161.
  • Platis, D. and Labrou, N.E. (2008) Chemical and genetic engineering strategies to improve the potency of pharmaceutical proteins and enzymes. Curr. Med. Chem. 15, 19401955.
  • Plesha, M.A., Huang, T.-K., Dandekar, A.M., Falk, B. and McDonald, K. (2009) Optimization of the bioprocessing conditions for scale-up of transient production of a heterologous protein in plants using a chemically inducible viral amplicon expression system. Biotechnol. Prog. 25, 722734.
  • Pogue, G.P., Lindbo, J.A., Dawson, W.O. and Turpen, T.H. (1998) Tobamovirus transient expression vectors: tools for plant biology and high-level expression of foreign proteins in plants. In Plant Molecular Biology Manual, Vol. L4 (Gelvin, S.B. and Schilperoot, R.A., eds), pp. 127. The Netherlands: Kluwer Academic Publishers.
  • Pogue, G.P., Lindbo, J.A., Garger, S.J. and Fitzmaurice, W.P. (2002) Making an ally from an enemy: plant virology and the new agriculture. Annu. Rev. Phytopathol. 40, 4574.
  • Pugach, P., Ketas, T.J., Michael, E. and Moore, J.P. (2008) Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors. Virology, 377, 401407.
  • Rademakers, L.M., Gründeman, P.F., Bolderman, R.W., Van Der Veen, F.H. and Maessen, J.G. (2009) Stability of an autologous platelet clot in the pericardial sac: an experimental and clinical study. J. Thorac. Cardiovasc. Surg. 137, 11901194.
  • Rival, S., Wisniewski, J.P., Langlais, A., Kaplan, H., Freyssinet, G., Vancanneyt, G., Vunsh, R., Perl, A. and Edelman, M. (2008) Spirodela (duckweed) as an alternative production system for pharmaceuticals: a case study, aprotinin. Transgenic Res. 4, 503513.
  • Sedrakyan, A., Treasure, T. and Elefteriades, J.A. (2004) Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J. Thorac. Cardiovasc. Surg. 128, 442448.
  • Sharma, A.K. and Sharma, M.K. (2009) Plants as bioreactors: recent developments and emerging opportunities. Adv. Biotech. 27, 811832.
  • Shearer, W.T., DeVille, J.G., Samson, P.M., Moye Jr, J.H.., Fletcher, C.V., Church, J.A., Spiegel, H.M., Palumbo, P., Fenton, T., Smith, M.E., Graham, B., Kraimer, J.M. and Olson, W.C. (2006) Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). J. Allergy Clin. Immunol. 118, 518521.
  • Shivprasad, S., Pogue, G.P., Lewandowski, D.J., Hidalgo, J., Donson, J., Grill, L.K. and Dawson, W.O. (1999) Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors. Virology, 255, 312323.
  • Sourrouille, C., Marshall, B., Liénard, D. and Faye, L. (2009) From Neanderthal to nanobiotech: from plant potions to pharming with plant factories. Methods Mol. Biol. 483, 123.
  • Stamou, S.C., Reames, M.K., Skipper, E., Stiegel, R.M., Nussbaum, M., Geller, R., Robicsek, F. and Lobdell, K.W. (2009) Aprotinin in cardiac surgery patients: is the risk worth the benefit? Eur. J. Cardiothorac. Surg. 36, 869875.
  • Sym, D., Patel, P.N. and El-Chaar, G.M. (2009) Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities. Ann. Pharmacother. 43, 20012011.
  • Szymkowski, D.E. (2004) Rational optimization of proteins as drugs: a new era of ‘medicinal biology’. Drug Discov. Today, 9, 381383.
  • Thiel, K.A. (2004) Biomanufacturing, from bust to boom….to bubble? Nat. Biotechnol. 22, 13651372.
  • Tissot, G., Canard, H., Nadai, M., Martone, A., Botterman, J. and Dubald, M. (2008) Translocation of aprotinin, a therapeutic protease inhibitor, into the thylakoid lumen of genetically engineered tobacco chloroplasts. Plant Biotechnol. J. 6, 309320.
  • Trkola, A., Ketas, T.J., Nagashima, K.A., Zhao, L., Cilliers, T., Morris, L., Moore, J.P., Maddon, P.J. and Olson, W.C. (2001) Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140. J. Virol. 75, 579588.
  • Turpen, T.H. (1999) Tobacco mosaic virus and the virescence of biotechnology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354, 665673.
  • Valdés, R., Gómez, L., Padilla, S., Brito, J., Reyes, B., Alvarez, T., Mendoza, O., Herrera, O., Ferro, W., Pujol, M., Leal, V., Linares, M., Hevia, Y., García, C., Milá, L., García, O., Sánchez, R., Acosta, A., Geada, D., Paez, R., Vega, J.L. and Borroto, C. (2003) Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plants. Biochem. Biophys. Res. Commun. 308, 94100.
  • Vézina, L.P., Faye, L., Lerouge, P., D’Aoust, M.A., Marquet-Blouin, E., Burel, C., Lavoie, P.O., Bardor, M. and Gomord, V. (2009) Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol. J. 7, 442455.
  • Weiner, L.M., Dhodapkar, M.V. and Ferrone, S. (2009) Monoclonal antibodies for cancer immunotherapy. Lancet, 373, 10331040.
  • Yang, S.J., Carter, S.A., Cole, A.B., Cheng, N.H. and Nelson, R.S. (2004) A natural variant of a host RNA-dependent RNA polymerase is associated with increased susceptibility to viruses by Nicotiana benthamiana. Proc. Natl Acad. Sci. USA, 101, 62976302.
  • Yina, J., Lib, G., Rena, X. and Herrle, G. (2007) Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J. Biotechnol. 127, 335347.
  • Zhong, Q., Xu, L., Zhang, C. and Glatz, C.E. (2007) Purification of recombinant aprotinin from transgenic corn germ fraction using ion exchange and hydrophobic interaction chromatography. Appl. Microbiol. Biotechnol. 76, 607613.